Concepedia

Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study

Derin Karacabeyli, Diane Lacaille, Na Lü, Natalie McCormick, Hui Xie, Hyon K. Choi, J. Antonio Aviña‐Zubieta

PLoS ONE · 2024 · 18 citations · 29 references

DOIFull text

Open access

Abstract

In patients with IMIDs and type 2 diabetes, GLP-1-RA exposure is associated with a lower risk of all-cause mortality and MACE compared to a cardioneutral active comparator.

References

29

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.2K citations

, , +21

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · BMJ · 2007 · 9.2K citations · Full text

, , +17

NF-κB signaling in inflammation

Ting Liu, Lingyun Zhang, Donghyun Joo et al. · Signal Transduction and Targeted Therapy · 2017 · 7.7K citations · Full text

Sensitivity Analysis in Observational Research: Introducing the E-Value

Tyler J. VanderWeele, Peng Ding · Annals of Internal Medicine · 2017 · 5.2K citations · Full text

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Patrick S. Romano, Leslíe L. Roos, James G. Jollis · Journal of Clinical Epidemiology · 1993 · 1.7K citations

, , +13